Journals / International Archives of Medical Research / 2011 / Cilt: 1 - Sayı: 1

A cross sectional study of autoantibodies in children with hepatitis A infection

Pages
1–7
Publication Date
2011-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, we conclude that further studies in larger populations will contribute to understanding of the relationship between the autoimmune disease and HA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Hepatitis A is one of the most frequently reported vaccine-preventable diseases worldwide and remains endemic in many areas of the world.
📊
Key Findings & Data:Method: A total of 52 patients diagnosed with hepatitis A (HA) were enrolled in this study.
💡
Conclusion & Impact:In addition, we conclude that further studies in larger populations will contribute to understanding of the relationship between the autoimmune disease and HA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Seroprevalence · autoantibodies · hepatitis A

Abstract

Background: Hepatitis A is one of the most frequently reported vaccine-preventable diseases worldwide and remains endemic in many areas of the world. The study aims to investigate the prevalence of autoantibodies in patients with acute viral hepatitis A. Method: A total of 52 patients diagnosed with hepatitis A (HA) were enrolled in this study. The diagnosis of acute hepatitis A (AHA) was based on negative hepatitis B surface antigen and hepatitis C virus RNA, and positive immunoglobulin (Ig) M HA antibody. Biochemical parameters and the presence of autoantibodies were recorded. Results: Prolonged protrombin time, international normalized ratio corrected with vitamin K and prolonged activated partial thromboplastin time were seen in 11, 11 and in 12 patients respectively. Total bilirubin levels were higher than 2 mg/dL in 21 patients and only five of these patients had direct bilirubin higher than 50% of the total bilirubin and serum bilirubin levels were higher than 10 mg/dL during at least 4 weeks. These 5 patients were evaluated as cholestatic hepatitis. Antinuclear antibodies were detected in four and anti-liver cytosolic antigen type 1 in one patient. Conclusion: The early diagnose of any autoimmune disease in patients with HA was found important since it may help take necessary precautions. In addition, we conclude that further studies in larger populations will contribute to understanding of the relationship between the autoimmune disease and HA.

🔖

Cite This Article

PIRINCCIOGLU, A. G., YALCIN, K., TÜZÜN, H., TASKESEN, M., ADIGÜZEL, S., SEVINC, S., BUDAK, D., BESTAS, R. (2011). A cross sectional study of autoantibodies in children with hepatitis A infection. International Archives of Medical Research, Cilt: 1 - Sayı: 1, 1–7. https://ajindex.com/articles/764835

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992;10;S56–S58. Shapiro CN. Hepatitis A virus In: Long SL, Pickering LK, Prober CG, editors. Principles and practice of pediatric infectious diseases. 2nd edition. London: Churchill Livingstone Inc.; 2003.
  2. Munoz Bertran E, Rosa Salazar V, Hostalet Robles F, et al. Autoimmune hepatitisis caused by acute hepatitisis due to hepatitisis A virus. Gastroenterol Hepatol 2002; 25: 501-504.
  3. Moon HW, Noh JK, Hur M, et al. High prevalence of autoantibodies in hepatitis A infection: the impact on laboratory profiles J Clin Pathol 2009; 62: 786-788.
  4. Hsieh MY, Dai CY, Lee LP, et al. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitisis C virus in patients with chronic hepatitisis C. J Clin Pathol 2008; 61:333-7.
  5. Yee LJ, Kelleher P, Goldin RD, et al. Antinuclear antibodies (ANA) in chronic hepatitisis C virus infection: correlates of positivity and clinical relevance. J Viral Hepat 2004;11: 459-64.
  6. Muratori P, Muratori L, Guidi M, et al. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitisis C. Clin Infect Dis 2005; 40: 501-7.
  7. Peng YC, Hsieh SC, Yang DY, et al. Expression and clinical significance of antinuclear antibody in hepatitisis C virus infection. J Clin Gastroenterol 2001; 33: 402-6.
  8. Cassani F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitisis C: comparison with autoimmune hepatitisis and impact on the disease profile. Hepatology 1997; 26: 561-6.
  9. Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitisis C. Hepatology 1995; 21: 613-9.
  10. Lenzi M, Bellentani S, Saccoccio G, et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 1999; 45: 435-41.
  11. Rigopoulou EI, Mytilinaiou M, Romanidou O, et al. Autoimmune hepatitisis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitisis. J Autoimmune Dis 2007; 4:2. Mikata R, Yokosuka O, Imazeki F, et al. Prolonged acute hepatitisis A mimicking autoimmune hepatitisis. World J Gastroenterol 2005;11: 3791-3.
  12. Rahaman SM, Chira P, Koff RS. Idiopathic autoimmune chronic hepatitisis triggered by hepatitisis A. Am J Gastroenterol 1994; 89:106-8.
  13. Tabak F, Ozdemir F,